CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the Jefferies 3rd Annual Healthcare Conference on Thursday, June 18, 2009, at 2:00 p.m. ET at the Mandarin Oriental in New York.
